Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

April 3, 2020

Study Completion Date

April 3, 2020

Conditions

Hypertension

Interventions

DRUG

CIN-107

A repeat oral dose of CIN-107 once daily for 10 days.

DRUG

Matching Placebo

A repeat oral dose of matching placebo once daily for 10 days.

Trial Locations (1)

Medpace Clinical Pharmacology Unit, Cincinnati